BIOForum Europe publishes a -Product Focus Spectrometer- article, featuring the Bruker Daltonics HCTultra ion trap

November 2005 - BIOForum Europe published a "Product Focus Spectrometer" article entitled "Mass Spectrometric Large-Scale Proteome Analysis", describing research done with the Bruker Daltonics HCTultra ion trap. "Mass spectrometers have become essential for the analysis of complex proteomes. Ion trap mass analysers are advantageous in proteomics applications due to their high duty cycle for a combined MS and MS/MS analysis, allowing successful protein (...)

Bruker Daltonics ultraflex MALDI TOF/TOF Mass Spectrometer - Product Review on biocompare.com

Mass spectrometry has become an essential technique in the field of proteomics as peptide mass fingerprinting and sequencing are now an important tool to identify unknown proteins. The purchase of the Ultraflex MALDI TOF/TOF instrument from Bruker Daltonics was to procure an instrument for accurate mass determination of different biological and chemical samples using only miniscule amounts of the material. Essentially, the Bruker Daltonics Ultraflex (...)

Taking the Lead in PTM Discovery – Explore Functional Proteomics

Research in the emerging field of proteome diversification requires sophisticated instrumentation to achieve satisfactory in-depth characterization of pharmaceutical proteins.

Bruker BioSciences Reports 6.4% Revenue Growth and Improved Operating Income, Net Income and Operating Cash Flow for the Third Quarter 2005

BILLERICA, Mass.--(BUSINESS WIRE)--Nov. 2, 2005--Bruker BioSciences Corporation (NASDAQ: BRKR) today reported third quarter 2005 revenue of $70.7 million, a 6.4% increase from revenue of $66.5 million in the third quarter of 2004. For the nine months ended September 30, 2005, revenue increased 9.2% to $217.0 million, compared to $198.8 million for the same period last year. Revenue growth during the three and nine months ended September 30, 2005 included (...)

Sebastian Meyer-Plath Joins Bruker Daltonics as Vice President of NBC Detection Business

BILLERICA, Mass.--(BUSINESS WIRE)--Nov. 1, 2005--Bruker Daltonics Inc. today announces that Sebastian Meyer-Plath has been appointed as the Company's Vice President for its Nuclear, Biological and Chemical (NBC) detection business, effective immediately.

Mr. Meyer-Plath will be responsible for Bruker Daltonics' global NBC detection business including strategy, marketing and sales management, its world-wide distribution organization, as well as other (...)

Bruker BioSciences Corporation to Release Third Quarter Financial Results on November 2, 2005

BILLERICA, Mass.--(BUSINESS WIRE)--Oct. 24, 2005--Bruker BioSciences Corporation (NASDAQ:BRKR) plans to release its third quarter 2005 financial results on Wednesday, November 2, 2005 after the market closes. Bruker BioSciences will then host an operator-assisted earnings conference call at 5 p.m. EST. To listen to the webcast, investors can go to www.bruker-biosciences.com and click on the live web broadcast symbol. The webcast will be available through (...)

Genetic Engineering News Interview

Genetic Engineering News interviewed Bruker Daltonics' Director of Proteomics Systems, Dr. Catherine Stacey, for their detailed front page story "Applying Mass Spec Tools in Proteomics." Dr. Stacey described the company's new HCTultra PTM discovery system. In addition, the extensive article addressed the Bruker Daltonics ClinProt solutions for biomarker discovery, validation, and identification.

UBS Global Life Sciences Conference

On September 28, 2005, 11:30 AM Eastern Time, Bruker BioSciences Corporation's Chairman, President & CEO, Frank H. Laukien, Ph.D., will present at the UBS Global Life Sciences Conference in New York. He will be accompanied by Bruker BioSciences Corp. CFO Bill Knight, CPA. To listen to the webcast live and view the slides, please...

Bear, Stearns & Co. Inc. 18th Annual Healthcare Conference

Dr. Laukien presented at the Bear, Stearns & Co. Inc. 18th Annual Healthcare Conference in New York, accompanied by CFO Bill Knight. To listen to a replay of the webcast and view the slides, please...

Bruker Daltonics Appoints Michael Schubert as Executive Vice President and Ian Sanders as Vice President

BILLERICA, Mass.--(BUSINESS WIRE)--Sept. 1, 2005--Bruker Daltonics Inc. today announces two promotions to further strengthen its senior management team.

Dr. Michael Schubert has been promoted to Executive Vice President of the Bruker Daltonics group. He retains his previous responsibilities for Bruker Daltonics' global R&D management, as well as his function as Managing Director (Geschaeftsfuehrer) of Bruker Daltonik GmbH, located in Bremen and (...)